Eudaimonia Partners’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2M Buy
15,933
+7,426
+87% +$850K 0.48% 47
2023
Q4
$897K Buy
8,507
+4,003
+89% +$437K 0.23% 93
2023
Q3
$477K Sell
4,504
-31
-0.7% -$3.59K 0.12% 178
2023
Q2
$540K Sell
4,535
-275
-6% -$28.4K 0.12% 172
2023
Q1
$447K Sell
4,810
-78
-2% -$6.84K 0.11% 197
2022
Q4
$400K Sell
4,888
-70
-1% -$5.32K 0.1% 202
2022
Q3
$303K Sell
4,958
-2,535
-34% -$186K 0.08% 245
2022
Q2
$524K Buy
7,493
+532
+8% +$38.9K 0.1% 211
2022
Q1
$576K Buy
+6,961
New +$564K 0.1% 220
2021
Q3
$665K Sell
7,629
-255
-3% -$22.5K 0.12% 203
2021
Q2
$614K Buy
7,884
+1,824
+30% +$143K 0.12% 204
2021
Q1
$425K Sell
6,060
-1,172
-16% -$75.9K 0.09% 221
2020
Q4
$468K Sell
7,232
-47
-0.6% -$2.8K 0.11% 195
2020
Q3
$435K Buy
7,279
+750
+11% +$42.6K 0.11% 189
2020
Q2
$361K Sell
6,529
-493
-7% -$26.1K 0.14% 168
2020
Q1
$339K Buy
7,022
+656
+10% +$33.9K 0.15% 159
2019
Q4
$337K Buy
+6,366
New +$350K 0.13% 172

Other funds holding ORCL

Eudaimonia Partners's ORCL Position: Q1 2024 in Review

Eudaimonia Partners increased its Oracle (ORCL) stake by 87% in Q1 2024, buying an estimated $850K and bringing the position to 15,933 shares worth $2M. The position accounts for 0.48% of the portfolio, ranked #47.

Eudaimonia Partners first reported a position in ORCL in Q4 2019 and has held it in 17 quarters since. 2,811 funds tracked by Wall St. Rank hold ORCL as of Q1 2024.

  • Eudaimonia Partners held 15,933 shares of Oracle worth $2M as of Q1 2024.
  • Eudaimonia Partners bought 7,426 Oracle shares in Q1 2024, an estimated $850K.
  • Oracle made up 0.48% of Eudaimonia Partners's portfolio in Q1 2024, its #47 holding.
  • Eudaimonia Partners first reported a position in Oracle in Q4 2019 and has held it in 17 quarters since.
  • 2,811 funds tracked by Wall St. Rank held Oracle as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.